Evaluation of a fibrin sealant free of bovine-derived components in an experimental vas anastomosis study

Olivier Vankemmel, Alexandre De La Taille, Thierry Burnouf, Jean Marc Rigot, Frank Duchene, Etienne Mazeman

Research output: Contribution to journalArticle

10 Citations (Scopus)

Abstract

Objectives: The risk of transmission of bovine spongiform encephalopathy cannot be excluded from the use of bovine-derived products. The present study was undertaken to evaluate the performance of a new fibrin glue free of bovine-derived components in vas anastomosis and to compare this product to conventional vas anastomosis with fibrin glue. Methods: Bilateral delayed vas anastomosis was performed in 40 Sprague-Dawley rats. All animals underwent a fibrin glue-assisted vas anastomosis with three transmural sutures tied prior to fibrin glue application. The composition and preparation of fibrin glue was similar for all vas anastomoses except the fibrinolysis inhibitor component which was aprotinin (3,000 KUI/ml) in group 1 and tranexamic acid (10 mg/ml) in group 2. The animals (20 rats in both groups) were sacrificed 7 weeks postoperatively and evaluated for gross patency, presence of sperm granuloma and tensile strength measurements at the anastomosis site. Results: No difference was found between the 2 groups for all parameters evaluated whether a bovine-derived or a synthetic fibrinolysis inhibitor component was used. Conclusion: This study showed that tranexamic acid, a fibrinolysis inhibitor, can be substituted for conventional fibrin glue thereby avoiding the risks of bovine products. Copyright (C) 2000 S. Karger AG, Basel.

Original languageEnglish
Pages (from-to)196-199
Number of pages4
JournalUrologia Internationalis
Volume65
Issue number4
Publication statusPublished - 2000
Externally publishedYes

Fingerprint

Fibrin Tissue Adhesive
Fibrinolysis
Tranexamic Acid
Bovine Spongiform Encephalopathy
Aprotinin
Tensile Strength
Granuloma
Sutures
Sprague Dawley Rats
Spermatozoa

Keywords

  • Aprotinin
  • Bovine spongiform encephalopathy
  • Fibrin adhesive
  • Tranexamic acid

ASJC Scopus subject areas

  • Urology

Cite this

Vankemmel, O., De La Taille, A., Burnouf, T., Rigot, J. M., Duchene, F., & Mazeman, E. (2000). Evaluation of a fibrin sealant free of bovine-derived components in an experimental vas anastomosis study. Urologia Internationalis, 65(4), 196-199.

Evaluation of a fibrin sealant free of bovine-derived components in an experimental vas anastomosis study. / Vankemmel, Olivier; De La Taille, Alexandre; Burnouf, Thierry; Rigot, Jean Marc; Duchene, Frank; Mazeman, Etienne.

In: Urologia Internationalis, Vol. 65, No. 4, 2000, p. 196-199.

Research output: Contribution to journalArticle

Vankemmel, O, De La Taille, A, Burnouf, T, Rigot, JM, Duchene, F & Mazeman, E 2000, 'Evaluation of a fibrin sealant free of bovine-derived components in an experimental vas anastomosis study', Urologia Internationalis, vol. 65, no. 4, pp. 196-199.
Vankemmel, Olivier ; De La Taille, Alexandre ; Burnouf, Thierry ; Rigot, Jean Marc ; Duchene, Frank ; Mazeman, Etienne. / Evaluation of a fibrin sealant free of bovine-derived components in an experimental vas anastomosis study. In: Urologia Internationalis. 2000 ; Vol. 65, No. 4. pp. 196-199.
@article{d0e4e58ffa0945898dc27e40e68bb263,
title = "Evaluation of a fibrin sealant free of bovine-derived components in an experimental vas anastomosis study",
abstract = "Objectives: The risk of transmission of bovine spongiform encephalopathy cannot be excluded from the use of bovine-derived products. The present study was undertaken to evaluate the performance of a new fibrin glue free of bovine-derived components in vas anastomosis and to compare this product to conventional vas anastomosis with fibrin glue. Methods: Bilateral delayed vas anastomosis was performed in 40 Sprague-Dawley rats. All animals underwent a fibrin glue-assisted vas anastomosis with three transmural sutures tied prior to fibrin glue application. The composition and preparation of fibrin glue was similar for all vas anastomoses except the fibrinolysis inhibitor component which was aprotinin (3,000 KUI/ml) in group 1 and tranexamic acid (10 mg/ml) in group 2. The animals (20 rats in both groups) were sacrificed 7 weeks postoperatively and evaluated for gross patency, presence of sperm granuloma and tensile strength measurements at the anastomosis site. Results: No difference was found between the 2 groups for all parameters evaluated whether a bovine-derived or a synthetic fibrinolysis inhibitor component was used. Conclusion: This study showed that tranexamic acid, a fibrinolysis inhibitor, can be substituted for conventional fibrin glue thereby avoiding the risks of bovine products. Copyright (C) 2000 S. Karger AG, Basel.",
keywords = "Aprotinin, Bovine spongiform encephalopathy, Fibrin adhesive, Tranexamic acid",
author = "Olivier Vankemmel and {De La Taille}, Alexandre and Thierry Burnouf and Rigot, {Jean Marc} and Frank Duchene and Etienne Mazeman",
year = "2000",
language = "English",
volume = "65",
pages = "196--199",
journal = "Urologia Internationalis",
issn = "0042-1138",
publisher = "S. Karger AG",
number = "4",

}

TY - JOUR

T1 - Evaluation of a fibrin sealant free of bovine-derived components in an experimental vas anastomosis study

AU - Vankemmel, Olivier

AU - De La Taille, Alexandre

AU - Burnouf, Thierry

AU - Rigot, Jean Marc

AU - Duchene, Frank

AU - Mazeman, Etienne

PY - 2000

Y1 - 2000

N2 - Objectives: The risk of transmission of bovine spongiform encephalopathy cannot be excluded from the use of bovine-derived products. The present study was undertaken to evaluate the performance of a new fibrin glue free of bovine-derived components in vas anastomosis and to compare this product to conventional vas anastomosis with fibrin glue. Methods: Bilateral delayed vas anastomosis was performed in 40 Sprague-Dawley rats. All animals underwent a fibrin glue-assisted vas anastomosis with three transmural sutures tied prior to fibrin glue application. The composition and preparation of fibrin glue was similar for all vas anastomoses except the fibrinolysis inhibitor component which was aprotinin (3,000 KUI/ml) in group 1 and tranexamic acid (10 mg/ml) in group 2. The animals (20 rats in both groups) were sacrificed 7 weeks postoperatively and evaluated for gross patency, presence of sperm granuloma and tensile strength measurements at the anastomosis site. Results: No difference was found between the 2 groups for all parameters evaluated whether a bovine-derived or a synthetic fibrinolysis inhibitor component was used. Conclusion: This study showed that tranexamic acid, a fibrinolysis inhibitor, can be substituted for conventional fibrin glue thereby avoiding the risks of bovine products. Copyright (C) 2000 S. Karger AG, Basel.

AB - Objectives: The risk of transmission of bovine spongiform encephalopathy cannot be excluded from the use of bovine-derived products. The present study was undertaken to evaluate the performance of a new fibrin glue free of bovine-derived components in vas anastomosis and to compare this product to conventional vas anastomosis with fibrin glue. Methods: Bilateral delayed vas anastomosis was performed in 40 Sprague-Dawley rats. All animals underwent a fibrin glue-assisted vas anastomosis with three transmural sutures tied prior to fibrin glue application. The composition and preparation of fibrin glue was similar for all vas anastomoses except the fibrinolysis inhibitor component which was aprotinin (3,000 KUI/ml) in group 1 and tranexamic acid (10 mg/ml) in group 2. The animals (20 rats in both groups) were sacrificed 7 weeks postoperatively and evaluated for gross patency, presence of sperm granuloma and tensile strength measurements at the anastomosis site. Results: No difference was found between the 2 groups for all parameters evaluated whether a bovine-derived or a synthetic fibrinolysis inhibitor component was used. Conclusion: This study showed that tranexamic acid, a fibrinolysis inhibitor, can be substituted for conventional fibrin glue thereby avoiding the risks of bovine products. Copyright (C) 2000 S. Karger AG, Basel.

KW - Aprotinin

KW - Bovine spongiform encephalopathy

KW - Fibrin adhesive

KW - Tranexamic acid

UR - http://www.scopus.com/inward/record.url?scp=0033773091&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0033773091&partnerID=8YFLogxK

M3 - Article

VL - 65

SP - 196

EP - 199

JO - Urologia Internationalis

JF - Urologia Internationalis

SN - 0042-1138

IS - 4

ER -